General Information of the Compound
| Compound ID |
CP0532436
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3R)-8-chloro-4-[[4-(5-methylpyridine-2-carbonyl)phenyl]methyl]-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepine-2,5-dione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H23ClN4O3
|
||||||||||||||||||
| Molecular Weight |
510.981
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc(nc1)C(=O)c1ccc(CN2[C@H](Cc3ccccn3)C(=O)Nc3cc(Cl)ccc3C2=O)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H23ClN4O3/c1-18-5-12-24(32-16-18)27(35)20-8-6-19(7-9-20)17-34-26(15-22-4-2-3-13-31-22)28(36)33-25-14-21(30)10-11-23(25)29(34)37/h2-14,16,26H,15,17H2,1H3,(H,33,36)/t26-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
MKHUGLYTGSIIHJ-AREMUKBSSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06635, Toxin A
Protein ID: PT04302, Toxin B